Abstract

Objective To investigate the imaging features observed in preoperative Gd-EOB-DTPA-dynamic enhanced MRI and correlated with the presence of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients. Methods 66 HCCs in 60 patients with preoperative Gd-EOB-DTPA-dynamic enhanced MRI were retrospectively analyzed. Features including tumor size, signal homogeneity, tumor capsule, tumor margin, peritumor enhancement during mid-arterial phase, peritumor hypointensity during hepatobiliary phase, signal intensity ratio on DWI and apparent diffusion coefficients (ADC), T1 relaxation times, and the reduction rate between pre- and postcontrast enhancement images were assessed. Correlation between these features and histopathological presence of MVI was analyzed to establish a prediction model. Results Histopathology confirmed that MVI were observed in 17 of 66 HCCs. Univariate analysis showed tumor size (p = 0.003), margin (p = 0.013), peritumor enhancement (p = 0.001), and hypointensity during hepatobiliary phase (p = 0.004) were associated with MVI. A multiple logistic regression model was established, which showed tumor size, margin, and peritumor enhancement were combined predictors for the presence of MVI (α = 0.1). R2 of this prediction model was 0.353, and the sensitivity and specificity were 52.9% and 93.0%, respectively. Conclusion Large tumor size, irregular tumor margin, and peritumor enhancement in preoperative Gd-EOB-DTPA-dynamic enhanced MRI can predict the presence of MVI in HCC.

Highlights

  • Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer related death worldwide and it is most frequently reported in East Asia [1]

  • We aim to investigate whether the imaging features identified during the preoperative Gd-EOB-DTPAdynamic enhanced Magnetic resonance imaging (MRI) can predict the presence of microvascular invasion (MVI) in patients with HCC

  • Patients were selected for this study based on the following inclusion criteria: (1) preoperative Gd-EOB-DTPAdynamic enhanced MR imaging was performed, (2) there is no prior surgical or medical treatment, (3) hepatic resection or transplantation was performed within 1 month after preoperative imaging, and (4) HCC was confirmed on histopathology

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer related death worldwide and it is most frequently reported in East Asia [1]. HCC frequently presents during its advanced stages and the survival rates remain poor with a 5-year recurrence rate of 25% after liver transplantation and 70% after hepatic resection [2,3,4]. The size, number, and nuclear grade of the tumors, presence of vascular invasion, and severity of liver disease are all regarded as important predictors for recurrence and poor survival outcomes [5, 6]. Vascular invasion is considered as an important prognostic factor for tumor metastasis [7]. The risk of recurrence after liver transplant was 4.4-fold higher in patients with

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call